INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

Continuing a tradition in an effort to raise awareness and find a cure for ovarian cancer, the National Ovarian Cancer ...

The selective CDK2 inhibitor INX-315 has been given FDA fast track designation for use in CCNE1-amplified, platinum-resistant ...

Angela Goodrich, 45, was shocked to be diagnosed with an extremely rare cancer. She shared her story and symptoms with TODAY ...

Polly’s Ice Cream & Espresso, a woman-owned business in Huntingdon Valley, PA, is celebrating World Ovarian Cancer Awareness ...

Mary Tipton Carter was diagnosed with cancer at 8 years old. Ten years later, she is continuing a tradition of making special gift baskets for other young patients.

Norton Healthcare Foundation is a charitable sponsor of the Kentucky Oaks Survivors Parade. Churchill Downs Foundation donates funds to support Norton Cancer Institute through Norton Healthcare ...

The Australian host of a weekend family lunch is on trial charged with murdering her estranged husband’s parents and an aunt ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on ...